Bruker Free Cash Flow 2010-2023 | BRKR
Bruker annual/quarterly free cash flow history and growth rate from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Bruker free cash flow for the quarter ending December 31, 2023 was 254.30, a year-over-year.
- Bruker free cash flow for the twelve months ending December 31, 2023 was , a year-over-year.
- Bruker annual free cash flow for 2023 was $0.254B, a 59.84% increase from 2022.
- Bruker annual free cash flow for 2022 was $0.159B, a 18.54% decline from 2021.
- Bruker annual free cash flow for 2021 was $0.195B, a 16.96% decline from 2020.
| Bruker Annual Free Cash Flow |
| 2023 |
254.30 |
| 2022 |
159.10 |
| 2021 |
195.30 |
| 2020 |
235.20 |
| 2019 |
151.40 |
| 2018 |
190.90 |
| 2017 |
122.20 |
| 2016 |
94.80 |
| 2015 |
195.90 |
| 2014 |
83.60 |
| 2013 |
96.10 |
| 2012 |
63.60 |
| 2011 |
33.30 |
| 2010 |
126.90 |
| 2009 |
133.50 |
| Bruker Quarterly Free Cash Flow |
| 2023-12-31 |
254.30 |
| 2023-09-30 |
80.10 |
| 2023-06-30 |
62.70 |
| 2023-03-31 |
73.20 |
| 2022-12-31 |
159.10 |
| 2022-09-30 |
22.10 |
| 2022-06-30 |
10.30 |
| 2022-03-31 |
71.50 |
| 2021-12-31 |
195.30 |
| 2021-09-30 |
84.20 |
| 2021-06-30 |
75.00 |
| 2021-03-31 |
74.50 |
| 2020-12-31 |
235.20 |
| 2020-09-30 |
60.90 |
| 2020-06-30 |
-3.90 |
| 2020-03-31 |
4.50 |
| 2019-12-31 |
151.40 |
| 2019-09-30 |
43.40 |
| 2019-06-30 |
-3.50 |
| 2019-03-31 |
3.60 |
| 2018-12-31 |
190.90 |
| 2018-09-30 |
78.60 |
| 2018-06-30 |
62.50 |
| 2018-03-31 |
35.30 |
| 2017-12-31 |
122.20 |
| 2017-09-30 |
26.30 |
| 2017-06-30 |
1.20 |
| 2017-03-31 |
27.70 |
| 2016-12-31 |
94.80 |
| 2016-09-30 |
14.90 |
| 2016-06-30 |
-12.20 |
| 2016-03-31 |
-21.40 |
| 2015-12-31 |
195.90 |
| 2015-09-30 |
57.50 |
| 2015-06-30 |
12.80 |
| 2015-03-31 |
21.30 |
| 2014-12-31 |
83.60 |
| 2014-09-30 |
21.20 |
| 2014-06-30 |
15.80 |
| 2014-03-31 |
9.90 |
| 2013-12-31 |
96.10 |
| 2013-09-30 |
-26.90 |
| 2013-06-30 |
-55.40 |
| 2013-03-31 |
-32.20 |
| 2012-12-31 |
63.60 |
| 2012-09-30 |
-5.10 |
| 2012-06-30 |
13.20 |
| 2012-03-31 |
-6.00 |
| 2011-12-31 |
33.30 |
| 2011-09-30 |
-42.80 |
| 2011-06-30 |
-56.80 |
| 2011-03-31 |
-39.30 |
| 2010-12-31 |
126.90 |
| 2010-09-30 |
42.20 |
| 2010-06-30 |
42.40 |
| 2010-03-31 |
0.10 |
| 2009-12-31 |
133.50 |
| 2009-09-30 |
58.40 |
| 2009-06-30 |
44.20 |
| 2009-03-31 |
9.20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$11.019B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
